Table 1 Baseline characteristics (demographics, measures of HIV disease and neuropsychiatric symptoms of HIV-only and HIV-TB co-infected (Rifampicin treatment) study participants at initiation of ART
Baseline demographics and measures of HIV disease | All participants (n=197) | HIV- patients (n=59) | HIV-TB patients (n=138) | P-value |
|---|---|---|---|---|
Proportion of female participants | 109 (55.3) | 40 (67.8) | 69 (50.4) | 0.02 |
Body weight at ART initiation / kg (±SD) | 53.6± 10.1 | 56.5 ± 9.8 | 51.9± 10.0 | 0.015 |
Age / years (±SD) | 33.8± 7.2 | 36.5 ± 6.1 | 32.7±7.4 | 0.003 |
Initial CD4 count (±SD) | 97.2± 77.4 | 123.1± 63.7 | 86.2± 79.9 | 0.009 |
Log10. viral load (±SD) | 4.95± 0.71 | 4.81± 0.73 | 5.02± 0.70 | 0.08 |
Baseline neuropsychiatric Symptoms | 61 (31) | 14 (23.7 ) | 47 (34.1) | 0.14 |
Sleep disorders | 36 (18.3) | 9(15.2) | 27 (19.7) | 0.46 |
Insomnia | 21 (10.7) | 6(10.2) | 15(10.9) | 0.88 |
Vivid dreams | 11 (5.6) | 4(6.9) | 7(5.2) | 0.66 |
Sleep walking | 9 (4.6) | 0(0.0) | 9 (6.67) | 0.04 |
Hallucinations | 3(1.5) | 1(1.7) | 2(1.5) | 0.9 |
   Auditory | 3(1.5) | 1(1.7) | 2(1.5) | 0.9 |
   Visual | 0(0.0) | 0(0.0) | 0(0.0) | - |
   Tactile | 0(0.0) | 0(0.0) | 0(0.0) | - |
Cognitive disorder | 46 (23.4) | 9(15.2) | 37 (27.0) | 0.07 |